Kilicarslan, RukiyeCakirca, MUSTAFAAydin, SİNEMOZKAN, TubaKOCAMAN, OrhanYolbas, ServetZorlu, MEHMETKaratoprak, CUMALİKiskac, MUHARREMCIKRIKCIOGLU, Mehmet AliERKOC, Reha2019-10-052019-10-052018-01-01Karatoprak C., Kilicarslan R., Cakirca M., Aydin S., OZKAN T., KOCAMAN O., Yolbas S., Zorlu M., Kiskac M., CIKRIKCIOGLU M. A. , et al., -Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus-, BEZMIALEM SCIENCE, cilt.6, ss.1-5, 2018https://hdl.handle.net/20.500.12645/1439Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.enArticleWOS:00043613780000210.14235/bs.2018.1050doi.org/10.14235/bs.2018.1050trdizin